Dow Jones

38 798,99

-0,22%

DAX

Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
NASDAQ
Abraxis Bioscience Inc. (MM) (ABII)
Abraxis Bioscience Inc. (MM) (ABII) Actualités

ABII

Abraxis Bioscience Inc. (MM) (ABII)

Abraxis Bioscience Inc. (MM)

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:NASDAQ:ABII

1 2 3 4 5 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
15/10/2010	19h03	Edgar (US Regulatory)	(25-NSE)	NASDAQ:ABII	Abraxis Bioscience Inc. (MM)
13/10/2010	22h30	Business Wire	Celgene and Abraxis Announce Shareholder Vote in Favor of Merger	NASDAQ:ABII	Abraxis Bioscience Inc. (MM)
12/10/2010	13h01	Edgar (US Regulatory)	Filing of certain prospectuses and communications in connection with business combination transactions (425)	NASDAQ:ABII	Abraxis Bioscience Inc. (MM)
06/10/2010	12h03	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (DEFA14A)	NASDAQ:ABII	Abraxis Bioscience Inc. (MM)
14/09/2010	23h24	Edgar (US Regulatory)	Proxy Statement - Merger or Acquistion (definitive) (DEFM14A)	NASDAQ:ABII	Abraxis Bioscience Inc. (MM)
10/09/2010	23h24	Edgar (US Regulatory)	Proxy Soliciting Materials (revised) (PRER14A)	NASDAQ:ABII	Abraxis Bioscience Inc. (MM)
05/08/2010	22h56	Edgar (US Regulatory)	Quarterly Report (10-Q)	NASDAQ:ABII	Abraxis Bioscience Inc. (MM)
29/07/2010	17h29	Dow Jones News	2nd UPDATE: Celgene 2Q Profit Up 8.8%; Again Boosts 2010 View	NASDAQ:ABII	Abraxis Bioscience Inc. (MM)
29/07/2010	15h45	Dow Jones News	UPDATE: Celgene 2Q Profit Up 8.8%; Again Increases 2010 View	NASDAQ:ABII	Abraxis Bioscience Inc. (MM)
29/07/2010	13h28	Edgar (US Regulatory)	Proxy Statement - Merger or Acquistion (preliminary) (PREM14A)	NASDAQ:ABII	Abraxis Bioscience Inc. (MM)
29/07/2010	11h00	Business Wire	Abraxis BioScience and Specialised Therapeutics Announce Approval to Market ABRAXANE for Metastatic Breast Cancer in New Zealand	NASDAQ:ABII	Abraxis Bioscience Inc. (MM)
23/07/2010	15h00	Business Wire	ABRAXANE® Approved for Marketing in Japan for Breast Cancer	NASDAQ:ABII	Abraxis Bioscience Inc. (MM)
19/07/2010	22h16	Business Wire	Bull & Lifshitz, LLP Announces Investigation of the Acquisition of Abraxis BioScience Inc.	NASDAQ:ABII	Abraxis Bioscience Inc. (MM)
12/07/2010	23h27	Business Wire	Faruqi & Faruqi, LLP Investigates Potential Breaches of Fiduciary Duties by the Board of Abraxis BioSciences, Inc. - ABII	NASDAQ:ABII	Abraxis Bioscience Inc. (MM)
09/07/2010	22h37	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:ABII	Abraxis Bioscience Inc. (MM)
08/07/2010	23h30	Edgar (US Regulatory)	Statement of Beneficial Ownership (SC 13D)	NASDAQ:ABII	Abraxis Bioscience Inc. (MM)
08/07/2010	01h41	Business Wire	The Law Office of Joseph Klein Investigates Possible Breach of Fiduciary Duty by the Board of Abraxis BioSciences Inc. - ABII	NASDAQ:ABII	Abraxis Bioscience Inc. (MM)
02/07/2010	22h29	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (SC 13D/A)	NASDAQ:ABII	Abraxis Bioscience Inc. (MM)
02/07/2010	17h36	Business Wire	Wolf Haldenstein Investigates Abraxis Bioscience, Inc. Proposed Acquisition	NASDAQ:ABII	Abraxis Bioscience Inc. (MM)
01/07/2010	23h24	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:ABII	Abraxis Bioscience Inc. (MM)
01/07/2010	03h30	Business Wire	Law Offices of Howard G. Smith Announces Investigation On Behalf of Shareholders of Abraxis BioScience, Inc.	NASDAQ:ABII	Abraxis Bioscience Inc. (MM)
01/07/2010	02h05	Business Wire	Robbins Umeda LLP Announces an Investigation of the Acquisition of Abraxis BioScience Inc. by Celgene Corporation	NASDAQ:ABII	Abraxis Bioscience Inc. (MM)
01/07/2010	00h16	Business Wire	Finkelstein Thompson LLP Announces Investigation of Abraxis Bioscience Inc.	NASDAQ:ABII	Abraxis Bioscience Inc. (MM)
30/06/2010	22h30	Business Wire	Ryan & Maniskas, LLP Announces Investigation of Abraxis BioScience, Inc.	NASDAQ:ABII	Abraxis Bioscience Inc. (MM)
30/06/2010	21h57	Dow Jones News	3rd UPDATE:Celgene Buy Of Abraxis Expands Cancer Treatment Push	NASDAQ:ABII	Abraxis Bioscience Inc. (MM)
30/06/2010	21h30	Dow Jones News	Abraxis Deal Value Depends On CVRs; CVRs Seen Undervalued	NASDAQ:ABII	Abraxis Bioscience Inc. (MM)
30/06/2010	20h54	Business Wire	Tripp Levy PLLC Investigates Buyout of Abraxis BioSciences	NASDAQ:ABII	Abraxis Bioscience Inc. (MM)
30/06/2010	19h14	Dow Jones News	2nd UPDATE:Celgene Buy Of Abraxis Expands Cancer Treatment Push	NASDAQ:ABII	Abraxis Bioscience Inc. (MM)
30/06/2010	19h01	Business Wire	Kendall Law Group Investigates Abraxis BioScience Inc. Merger for Shareholders	NASDAQ:ABII	Abraxis Bioscience Inc. (MM)
30/06/2010	19h00	Business Wire	Goldfarb Branham Law Firm LLP Investigating Potentially Unfair Buyout of Abraxis	NASDAQ:ABII	Abraxis Bioscience Inc. (MM)